Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

ACT Genomics raises $12.5M series B

May 7, 2016 12:36 AM UTC

Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn Technologies, Hua Nan Venture Capital, President International Development and UMC Capital also participated. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article